Introduction: Neoadjuvant chemoimmunotherapy has achieved overall survival (OS) benefit for patients with resectable non-small cell lung cancer (NSCLC). Here, we present outcomes after 3 years of follow-up from the first reported study of neoadjuvant atezolizumab+chemotherapy.
Methods: This open-label, multicenter single-arm investigator-initiated phase II study conducted at three US hospitals tested up to four cycles of atezolizumab, carboplatin, and nab-paclitaxel prior to surgery.
Introduction Anthracosis is black discoloration of the bronchi, which can sometimes cause anthracofibrosis. Usually, exposure to biomass fuel, air pollution, or smoke at the workplace causes it. The objective of the current study was to determine the association between tuberculosis and anthracosis.
View Article and Find Full Text PDFIn this work, poly(styrene)@poly(-isopropylmethacrylamide--2-(,-dimethyl)aminoethyl methacrylate [p(sty)@p(NIPMAM-DMAEMA)] core/shell microgel particles were produced by a two-step free-radical precipitation polymerization process. Ag nanoparticles were successfully embedded inside the sieves of a crosslinked network by using silver nitrate as the precursor salt and NaBH as the reductant. The synthesized pure and hybrid microgels were analyzed by various characterization tools, including Fourier transform infrared (FTIR) and UV-visible (UV-vis) spectroscopies, transmission electron microscopy (TEM) and dynamic light scattering (DLS).
View Article and Find Full Text PDF